Shanghai Kehua Bio-engineering Co Ltd.
002022
Overview
Corporate Details
- ISIN(s):
- CNE000001KC9
- LEI:
- Country:
- China
- Address:
- N/A
- Website:
- N/A
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
Automate Your Workflow. Get a real-time feed of all Shanghai Kehua Bio-engineering Co Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Shanghai Kehua Bio-engineering Co Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Shanghai Kehua Bio-engineering Co Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Clinical-stage oncology company developing novel protein degraders and ADCs for cancer.
United States of America
PRLD
United States of America
PRLD
South Korea
334970
Singapore
950210
Develops and markets leading over-the-counter brands for personal healthcare and wellness.
United States of America
PBH
United States of America
PBH
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America
PRME
United States of America
PRME
Develops and manufactures clinically proven probiotics for B2B supplement & nutrition partners.
Sweden
PROB
Sweden
PROB
United Kingdom
PBX
Develops next-gen chemo and therapies for chronic and life-threatening diseases.
United States of America
PCSA
United States of America
PCSA
South Korea
296160
Develops cellular therapies to preserve kidney function for patients with advanced Chronic Kidney Disease.
United States of America
PROK
United States of America
PROK